Citations

Showing 10 of 108083 citations.

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
Bhanji, Rahima A. , Narayanan, Praveena , Watt, Kymberly D. , Malhi, Harmeet , Allen, Alina M.

Mayo Clinic

Hepatology | August 4, 2017 | Volume: 66 | Issue: 6 | Pages: 2055-2065

10.1002/hep.29420 | PMID 28777879 Get It

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Up to one third of individuals with NAFLD will develop nonalcoholic steatohepatitis (NASH), which is associated with progression to cirrhosis and is rapidly becoming the leading indication for liver transplantation. Sarcopenia is defined as a progressive and generalized loss of skeletal muscle mass, strength, and function. It is observed in up to 60% of patients with end‐stage liver disease and portends a poor prognosis. Recent studies have shown that sarcopenia is a novel risk factor for developing NAFLD. Pathophysiological mechanisms relating sarcopenia and NASH may include insulin resistance (IR) and increased inflammation. IR leads to accumulation of triglycerides in both muscle tissue and the liver. It also exacerbates proteolysis and leads to muscle depletion. Chronic inflammation leads to liver injury and progression of fibrosis. The inflammatory milieu also stimulates protein catabolism. Viewing skeletal muscle as an endocrine organ that secretes various salutary myokines may help us understand its role in the development of steatosis. A better understanding of the pathophysiology will aid in developing physical and pharmacological therapeutic interventions. In this review, we will explore the complex inter‐relationships between sarcopenia and NASH. We will discuss the impact of sarcopenia in patients with NASH and therapeutic options for the management of sarcopenia. (Hepatology 2017;66:2055–2065)
Ablation of Musculoskeletal Metastases
Callstrom, Matthew R. , Kurup, A. Nicholas , Morris, Jonathan M.

Mayo Clinic

American Journal of Roentgenology | August 4, 2017 | Volume: 209 | Issue: 4 | Pages: 713-721

10.2214/ajr.17.18527 | PMID 28777648 Get It

Technical Note: Using experimentally determined proton spot scanning timing parameters to accurately model beam delivery time
Shen, Jiajian , Tryggestad, E., Younkin, James E. , Keole, Sameer R., Kang, Yixiu, Herman, Michael , Bues, Martin , Tryggestad, Erik, Furutani, Keith M. , Herman, Michael G., Shen, Jiajian , Bues, Martin

Mayo Clinic

Medical Physics | August 4, 2017 | Volume: 44 | Issue: 10 | Pages: 5081-5088

10.1002/mp.12504 | PMID 28777447 Get It

PurposeTo accurately model the beam delivery time (BDT) for a synchrotron‐based proton spot scanning system using experimentally determined beam parameters.MethodsA model to simulate the proton spot delivery sequences was constructed, and BDT was calculated by summing times for layer switch, spot switch, and spot delivery. Test plans were designed to isolate and quantify the relevant beam parameters in the operation cycle of the proton beam therapy delivery system. These parameters included the layer switch time, magnet preparation and verification time, average beam scanning speeds in x‐ and y‐directions, proton spill rate, and maximum charge and maximum extraction time for each spill. The experimentally determined parameters, as well as the nominal values initially provided by the vendor, served as inputs to the model to predict BDTs for 602 clinical proton beam deliveries. The calculated BDTs (TBDT) were compared with the BDTs recorded in the treatment delivery log files (TLog): ∆t = TLog−TBDT.ResultsThe experimentally determined average layer switch time for all 97 energies was 1.91 s (ranging from 1.9 to 2.0 s for beam energies from 71.3 to 228.8 MeV), average magnet preparation and verification time was 1.93 ms, the average scanning speeds were 5.9 m/s in x‐direction and 19.3 m/s in y‐direction, the proton spill rate was 8.7 MU/s, and the maximum proton charge available for one acceleration is 2.0 ± 0.4 nC. Some of the measured parameters differed from the nominal values provided by the vendor. The calculated BDTs using experimentally determined parameters matched the recorded BDTs of 602 beam deliveries (∆t = −0.49 ± 1.44 s), which were significantly more accurate than BDTs calculated using nominal timing parameters (∆t = −7.48 ± 6.97 s).ConclusionsAn accurate model for BDT prediction was achieved by using the experimentally determined proton beam therapy delivery parameters, which may be useful in modeling the interplay effect and patient throughput. The model may provide guidance on how to effectively reduce BDT and may be used to identifying deteriorating machine performance.
Comprehensive biomechanical analysis of three reconstruction techniques following total sacrectomy: an in vitro human cadaveric model
Macki, Mohamed, Ramos, Rafael De la Garza , Murgatroyd, Ashley A., Mullinix, Kenneth P., Cunningham, Bryan W. , McCutcheon, Brandon A., Bydon, Mohamad , Gokaslan, Ziya L. , Sun, Xiaolei , De la Garza Ramos, Rafael

Mayo Clinic

Journal of Neurosurgery: Spine | August 4, 2017 | Volume: 27 | Issue: 5 | Pages: 570-577

10.3171/2017.2.spine161128 | PMID 28777063 Get It

OBJECTIVEAggressive sacral tumors often require en bloc resection and lumbopelvic reconstruction. Instrumentation failure and pseudarthrosis remain a clinical concern to be addressed. The objective in this study was to compare the biomechanical stability of 3 distinct techniques for sacral reconstruction in vitro.METHODSIn a human cadaveric model study, 8 intact human lumbopelvic specimens (L2–pelvis) were tested for flexion-extension range of motion (ROM), lateral bending, and axial rotation with a custom-designed 6-df spine simulator as well as axial compression stiffness with the MTS 858 Bionix Test System. Biomechanical testing followed this sequence: 1) intact spine; 2) sacrectomy (no testing); 3) Model 1 (L3–5 transpedicular instrumentation plus spinal rods anchored to iliac screws); 4) Model 2 (addition of transiliac rod); and 5) Model 3 (removal of transiliac rod; addition of 2 spinal rods and 2 S-2 screws). Range of motion was measured at L4–5, L5–S1/cross-link, L5–right ilium, and L5–left ilium.RESULTSFlexion-extension ROM of the intact specimen at L4–5 (6.34° ± 2.57°) was significantly greater than in Model 1 (1.54° ± 0.94°), Model 2 (1.51° ± 1.01°), and Model 3 (0.72° ± 0.62°) (p < 0.001). Flexion-extension at both the L5–right ilium (2.95° ± 1.27°) and the L5–left ilium (2.87° ± 1.40°) for Model 3 was significantly less than the other 3 cohorts at the same level (p = 0.005 and p = 0.012, respectively). Compared with the intact condition, all 3 reconstruction groups statistically significantly decreased lateral bending ROM at all measured points. Axial rotation ROM at L4–5 for Model 1 (2.01° ± 1.39°), Model 2 (2.00° ± 1.52°), and Model 3 (1.15° ± 0.80°) was significantly lower than the intact condition (5.02° ± 2.90°) (p < 0.001). Moreover, axial rotation for the intact condition and Model 3 at L5–right ilium (2.64° ± 1.36° and 2.93° ± 1.68°, respectively) and L5–left ilium (2.58° ± 1.43° and 2.93° ± 1.71°, respectively) was significantly lower than for Model 1 and Model 2 at L5–right ilium (5.14° ± 2.48° and 4.95° ± 2.45°, respectively) (p = 0.036) and L5–left ilium (5.19° ± 2.34° and 4.99° ± 2.31°) (p = 0.022). Last, results of the axial compression testing at all measured points were not statistically different among reconstructions.CONCLUSIONSThe addition of a transverse bar in Model 2 offered no biomechanical advantage. Although the implementation of 4 iliac screws and 4 rods conferred a definitive kinematic advantage in Model 3, that model was associated with significantly restricted lumbopelvic ROM.
Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998–2009
McCutcheon, Brandon A., Hirshman, Brian R. , Gabel, Brandon, Heffner, Michael , Marcus, Logan P., Cole, Tyler S. , Chen, Clark C. , Chang, David C. , Carter, Bob S.

Mayo Clinic

Journal of Neurosurgery | August 4, 2017 | Volume: 128 | Issue: 5 | Pages: 1578-1588

10.3171/2016.4.jns152332 | PMID 28777023 Get It

OBJECTIVEThe subspecialization of neurosurgical practice is an ongoing trend in modern neurosurgery. However, it remains unclear whether the degree of surgeon specialization is associated with improved patient outcomes. The authors hypothesized that a trend toward increased neurosurgeon specialization was associated with improved patient morbidity and mortality rates.METHODSThe Nationwide Inpatient Sample (NIS) was used (1998–2009). Patients were included in a spinal analysis cohort for instrumented spine surgery involving the cervical spine (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 81.31–81.33, 81.01–81.03, 84.61–84.62, and 84.66) or lumbar spine (codes 81.04–81.08, 81.34–81.38, 84.64–84.65, and 84.68). A cranial analysis cohort consisted of patients receiving a parenchymal excision or lobectomy operation (codes 01.53 and 01.59). Surgeon specialization was measured using unique surgeon identifiers in the NIS and defined as the proportion of a surgeon’s total practice dedicated to cranial or spinal cases.RESULTSA total of 46,029 and 231,875 patients were identified in the cranial and spinal analysis cohorts, respectively. On multivariate analysis in the cranial analysis cohort (after controlling for overall surgeon volume, patient demographic data/comorbidities, hospital characteristics, and admitting source), each percentage-point increase in a surgeon’s cranial specialization (that is, the proportion of cranial cases) was associated with a 0.0060 reduction in the log odds of patient mortality (95% CI 0.0034–0.0086) and a 0.0042 reduction in the log odds of morbidity (95% CI 0.0032–0.0052). This resulted in a 15% difference in the predicted probability of mortality for neurosurgeons at the 75th versus the 25th percentile of cranial specialization. In the spinal analysis cohort, each percentage-point increase in a surgeon’s spinal specialization was associated with a 0.0122 reduction in the log odds of mortality (95% CI 0.0074–0.0170) and a 0.0058 reduction in the log odds of morbidity (95% CI 0.0049–0.0067). This resulted in a 26.8% difference in the predicted probability of mortality for neurosurgeons at the 75th versus the 25th percentile of spinal specialization.CONCLUSIONSFor both spinal and cranial surgery patient cohorts derived from the NIS database, increased surgeon specialization was significantly and independently associated with improved mortality and morbidity rates, even after controlling for overall case volume.
An Interposed Pad in Open‐Chest Echocardiographic Porcine Scans for Mimicking Ultrasound Signal Attenuation in a Human Chest
Kinnick, Randall R., Katayama, Minako , Bëlohlávek, Marek

Mayo Clinic

Journal of Ultrasound in Medicine | August 4, 2017 | Volume: 37 | Issue: 2 | Pages: 501-509

10.1002/jum.14351 | PMID 28777479 Get It

Opening a chest in an experimental echocardiographic animal study eliminates ultrasound signal attenuation by the chest wall. We developed a scanning technique that involves the use of an attenuative pad created from a mixture of urethane and titanium dioxide. The pad was interposed within transmission gel between the transducer face and cardiac surface in open‐chest scans in a porcine model. Comparative measurements of left ventricular echogenicity without and with the pad demonstrate that the pad reproducibly causes ultrasound signal attenuation that closely mimics chest attenuation in clinical transthoracic echocardiographic studies.
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy
Killu, Ammar M. , Mazo, Anna, Grupper, Avishay , Madhavan, Malini , Webster, Tracy L., Brooke, Kelly L., Hodge, David O. , Asirvatham, Samuel J. , Friedman, Paul A. , Glikson, Michael , Cha, Yong‐Mei , Webster, Tracy, Asirvatham, Samuel J , Glikson, Michael

Mayo Clinic

EP Europace | August 4, 2017 | Volume: 20 | Issue: 8 | Pages: 1303-1311

10.1093/europace/eux235 | PMID 29016821 Get It

On Patient Flow in Hospitals: A Data-Based Queueing-Science Perspective
Armony, Mor , Israelit, Shlomo, Mandelbaum, Avishai , Marmor, Yariv N. , Tseytlin, Yulia, Yom-Tov, Galit B., Yom‐Tov, Galit B.

Mayo Clinic

Stochastic Systems | August 4, 2017 | Volume: 5 | Issue: 1 | Pages: 146-194

10.1287/14-ssy153 Get It

Hospitals are complex systems with essential societal benefits and huge mounting costs. These costs are exacerbated by inefficiencies in hospital processes, which are often manifested by congestion and long delays in patient care. Thus, a queueing-network view of patient flow in hospitals is natural for studying and improving its performance. The goal of our research is to explore patient flow data through the lens of a queueing scientist. The means is exploratory data analysis (EDA) in a large Israeli hospital, which reveals important features that are not readily explainable by existing models. Questions raised by our EDA include: Can a simple (parsimonious) queueing model usefully capture the complex operational reality of the Emergency Department (ED)? What time scales and operational regimes are relevant for modeling patient length of stay in the Internal Wards (IWs)? How do protocols of patient transfer between the ED and the IWs influence patient delay, workload division and fairness? EDA also underscores the importance of an integrative view of hospital units by, for example, relating ED bottlenecks to IW physician protocols. The significance of such questions and our related findings raise the need for novel queueing models and theory, which we present here as research opportunities. Hospital data, and specifically patient flow data at the level of the individual patient, is increasingly collected but is typically confidential and/or proprietary. We have been fortunate to partner with a hospital that allowed us to open up its data for everyone to access. This enables reproducibility of our findings, through a user-friendly platform that is accessible via the Technion SEELab.
An exploratory genome-wide analysis of genetic risk for alcoholic hepatitis
Beaudoin, James J. , Long, Nanye, Liangpunsakul, Suthat , Puri, Puneet , Kamath, Patrick S. , Shah, Vijay H. , Crabb, David W. , Chalasani, Naga , Urban, Thomas, Consortium, for the TREAT, Shah, Vijay, Sanyal, Arun J. , Consortium, for the TREAT

Mayo Clinic

Scandinavian Journal of Gastroenterology | August 4, 2017 | Volume: 52 | Issue: 11 | Pages: 1263-1269

10.1080/00365521.2017.1359664 | PMID 28776448 Get It

Criteria for Risk Stratification of Vulvar and Vaginal Smooth Muscle Tumors
Sayeed, Sadia , Xing, Deyin , Weisman, Paul , Buehler, Darya, Warmke, Laura M. , Uram–Tuculescu, Cora, Howitt, Brooke E. , Cortese, Cherise , Schoolmeester, J. Kenneth , Jenkins, Sarah , Bakkum‐Gamez, Jamie N. , Park, Kay J.

Mayo Clinic

American Journal of Surgical Pathology | August 4, 2017 | Volume: 42 | Issue: 1 | Pages: 84-94

10.1097/pas.0000000000000920 | PMID 28786880 Get It

Accurate risk stratification of smooth muscle tumors (SMTs) is essential for appropriate patient management. Yet, the rarity of SMTs of the vagina and vulva makes development of a prognostically meaningful classification system challenging. While 2 classification methods for vulvar SMTs and 1 for vaginal SMTs have been proposed, it is our experience that many pathologists tend to apply criteria for uterine SMTs when evaluating vulvovaginal tumors. We retrospectively reviewed a large cohort of vulvovaginal SMTs with clinical follow-up and evaluated which method most accurately classified tumors according to patient outcome. A total of 71 tumors, 53 vaginal (75%) and 18 vulvar (25%), from 71 patients were identified. All tumors were centrally examined for degree of cytologic atypia, morphology (spindled, epithelioid, myxoid), mitotic index per 10 high power fields, atypical mitotic figures, tumor cell necrosis, ischemic necrosis, tumor interface (circumscribed or infiltrative) and margin status. Clinical features were recorded for each patient. Follow-up was available for 63 patients (89%), and ranged from 1 to 234 months (median: 64 mo). While site-specific and uterine criteria showed equally excellent sensitivity in classifying smooth muscle neoplasms as leiomyosarcoma according to patient outcome, uterine criteria showed improved specificity relatively to site-specific methods in classifying tumors as nonsarcoma according to patient outcome. We recommend that uterine SMT criteria and nomenclature be adopted for evaluation and classification of vulvovaginal SMTs.